Stay updated on Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Sign up to get notified when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.

Latest updates to the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed as a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or layout are evident from the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedA 'Show glossary' option was added and the page's QC/revision metadata was updated to 'Last Update Submitted that Met QC Criteria' with revision 'v3.4.0' (replacing the prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedA minor platform revision label updated from v3.3.3 to v3.3.4. No study details or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing sites in Coahuila, Guerrero, Hidalgo, Jalisco, Michoacán, and Morelos, and updated the documentation to Revision 3.3.3. Removed the separate state-location entries (Coahuila Locations, Guerrero Locations, Hidalgo Locations, Jalisco Locations, Michoacán Locations, Morelos Locations) and the HHS Vulnerability Disclosure link to reflect the updated page structure.SummaryDifference0.8%

- Check92 days agoChange DetectedRevision metadata updated: v3.3.2 added and v3.2.0 removed. These are minor metadata changes and do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Recombinant vs Marketed Flu Vaccines in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant vs Marketed Flu Vaccines in Children Clinical Trial page.